Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2

被引：0
|
作者：
SM Johnson
JA Shaw
RA Walker
机构：
[1] University of Leicester,Breast Cancer Research Unit
[2] Clinical Sciences,undefined
[3] Glenfield Hospital,undefined
来源：
Breast Cancer Research | / 2卷 / Suppl 1期
关键词：
Breast Cancer; Paraffin; Young Woman; Pathological Feature; Full Text;
D O I：
10.1186/bcr96
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations
    Metcalfe, Kelly A.
    WOMENS HEALTH, 2009, 5 (01) : 63 - 68
  • [32] Recurrent BRCA1 and BRCA2 Mutations in Mexican Women with Breast Cancer
    Torres-Mejia, Gabriela
    Royer, Robert
    Llacuachaqui, Marcia
    Akbari, Mohammad R.
    Giuliano, Anna R.
    Martinez-Matsushita, Louis
    Angeles-Llerenas, Angelica
    Ortega-Olvera, Carolina
    Ziv, Elad
    Lazcano-Ponce, Eduardo
    Phelan, Catherine M.
    Narod, Steven A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (03) : 498 - 505
  • [33] BRCA1/BRCA2 (BRCA) testing in young women with breast cancer: patterns; motivations and implications for treatment decisions
    Rosenberg, S.
    Ruddy, K.
    Tamimi, R.
    Gelber, S.
    Schapira, L.
    Come, S.
    Borges, V.
    Larsen, B.
    Garber, J.
    Partridge, A.
    BREAST, 2014, 23 : S8 - S8
  • [34] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Kotsopoulos, Joanne
    Gronwald, Jacek
    Huzarski, Tomasz
    Aeilts, Amber
    Armel, Susan Randall
    Karlan, Beth
    Singer, Christian
    Eisen, Andrea
    Tung, Nadine
    Olopade, Olufunmilayo
    Bordeleau, Louise
    Eng, Charis
    Foulkes, William
    Neuhausen, Susan
    Cullinane, Carey
    Pal, Tuya
    Fruscio, Robert
    Lubinski, Jan
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 257 - 264
  • [35] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Joanne Kotsopoulos
    Jacek Gronwald
    Tomasz Huzarski
    Amber Aeilts
    Susan Randall Armel
    Beth Karlan
    Christian F. Singer
    Andrea Eisen
    Nadine Tung
    Olufunmilayo Olopade
    Louise Bordeleau
    Charis Eng
    William D. Foulkes
    Susan L. Neuhausen
    Carey A. Cullinane
    Tuya Pal
    Robert Fruscio
    Jan Lubinski
    Kelly Metcalfe
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2023, 201 : 257 - 264
  • [36] Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
    Yao, Lu
    Sun, Jie
    Zhang, Juan
    He, Yingjian
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 441 - 445
  • [37] BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women
    Gilbert, F
    Dabney, MK
    Diemer, K
    Ludwig, S
    Rosenthal, G
    Osborne, MP
    CANCER: GENETICS AND THE ENVIRONMENT, 1997, 833 : 198 - 203
  • [38] Diabetes and Breast Cancer Among Women With BRCA1 and BRCA2 Mutations
    Bordeleau, Louise
    Lipscombe, Lorraine
    Lubinski, Jan
    Ghadirian, Parviz
    Foulkes, William D.
    Neuhausen, Susan
    Ainsworth, Peter
    Pollak, Michael
    Sun, Ping
    Narod, Steven A.
    CANCER, 2011, 117 (09) : 1812 - 1818
  • [39] Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer
    Chappuis, PO
    Hamel, N
    Paradis, AJ
    Deschênes, J
    Robidoux, A
    Potvin, C
    Cantin, J
    Tonin, P
    Ghadirian, P
    Foulkes, WD
    CLINICAL GENETICS, 2001, 59 (06) : 418 - 423
  • [40] Pregnancy and breast cancer risk in women with BRCA1 or BRCA2 mutations
    Carol Lovegrove
    Nature Clinical Practice Oncology, 2006, 3 (1): : 9 - 9
12345